As the Obama administration praises the benefits of the Trans-Pacific Partnership (TPP), backlash continues to grow against the deal. WikiLeaks has just published another section of the secret text — this one about public healthcare and the pharmaceutical industry. Newly revealed details of the draft show the TPP would give major pharmaceutical companies more power over public access to medicine and weaken public healthcare programs. The leaked draft also suggests the TPP would prevent Congress from passing reforms to lower drug costs. One of the practices that would be allowed is known as “evergreening.” It lets drug companies extend the life of a patent by slightly modifying their product and then getting a new patent. We speak to Peter Maybarduk of Public Citizen and John Sifton of Human Rights Watch about their concerns.